Combination of traditional Chinese medicine and western medicine in the treatment of common type novel coronavirus pneumonia (COVID-19)

Combination of traditional chinese medicne and western medicine in the treatment of common type novel coronavirus pneumonia (COVID-19)

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000029439

Enrollment

Unknown

Registered

2020-02-01

Start date

2020-02-02

Completion date

Unknown

Last updated

2020-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

novel coronavirus pneumonia (COVID-19)

Interventions

control group:basic western medical therapies

experimental group:TCM standard decoctions+basic western medical therapies

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) patients diagnosed as Pneumonia caused by new coronavirus infection (2019-nCoV); 2) The classification was judged as common type; 3) Informed consent.

Exclusion criteria

Exclusion criteria: 1) Pregnant or lactating women; 2) Severe basic diseases that affect survival; 3) Other problems thant doctor's judgment is not suitable for the study; 4) Patients have difficulty in taking TCM standard decoctions.

Design outcomes

Primary

Measure	Time frame
Antipyretic time;Time of virus turning negative;	—

Secondary

Measure	Time frame
Pulmonary function;conversion rate of severe cases;Inflammation index;Disappearance time of gastrointestinal symptoms;Syndrome of traditional Chinese Medicine;Adverse events;	—

Countries

China

Contacts

Public ContactWANG YUGUANG, LI XUCHENG, ZHANG BOLI

Beijing Hospital of Traditional Chinese Medicine affiliated to Capital Medical University/Beijing institute of Traditional Chinese Medicine

ZJHTCM@FOXMAIL.COM+86 13902020873

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026